2h-1,4-benzoxazine, 3,4-dihydro-2,2-dimethyl-6-nitro-4-(2-pyridinyl)-, n-oxide has been researched along with Hypoxia in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 1 (100.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Ando, T; Konishi, F; Koshimizu, M; Morinaka, T; Taguchi, T; Takeo, S; Tanonaka, K; Yogo, T | 1 |
1 other study(ies) available for 2h-1,4-benzoxazine, 3,4-dihydro-2,2-dimethyl-6-nitro-4-(2-pyridinyl)-, n-oxide and Hypoxia
Article | Year |
---|---|
Role of an ATP-sensitive potassium channel opener, YM934, in mitochondrial energy production in ischemic/reperfused heart.
Topics: Adenosine Triphosphate; Animals; Anti-Arrhythmia Agents; Benzoxazines; Creatine Kinase; Cyclic N-Oxides; Decanoic Acids; Dose-Response Relationship, Drug; Drug Interactions; Glyburide; Heart Ventricles; Hemodynamics; Hydroxy Acids; Hypoxia; In Vitro Techniques; Male; Mitochondria, Heart; Oxazines; Oxygen Consumption; Perfusion; Phosphocreatine; Rats; Rats, Wistar; Reperfusion Injury; Time Factors | 1999 |